Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 62, Issue 4, 1996, Pages 1021-1025

  Yoshino, Ichiro ^a   Yokoyama, Hideki ^a   Yano, Tokujiro ^a   Ueda, Takashi ^a   Takai, Eiji ^a   Mizutani, Kazuki ^a   Asoh, Hiroshi ^a   Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030271399     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00470-5     Document Type: Article

References (19)

1. 1. Massen W. Accuracy of mediastinoscopy. In: DeLarue NL, Eschapasse H, eds. International trends in general thoracic surgery. Philadelphia: Saunders, 1985:42-53.
2. 2. Martini N, Flehniger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-97.
3. 3. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225-33.
4. 4. Miller DL, McManus KG, Allen MS, et al. Results of surgical resection in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994;57:1095-101.
5. 5. Daly BT, Mueller JD, Faling LJ, et al. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 1993; 105:904-11.
6. 6. Patterson GA, Piazza O, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987;43:155-9.
7. 7. Ishida T, Yano T, Maeda K, Kaneko S, Tateishi M, Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990;50: 708-13.
8. 8. Tateishi M, Fukuyama Y, Hamatake M, Kohdono S, Ishida T, Sugimachi K. Skip mediastinal lymph node metastasis in non-small cell lung cancer. J Surg Oncol 1994;57:139-42.
9. 9. The World Health Organization. Histological typing of lung tumors. Am J Clin Pathol 1982;57:471-6.
10. 10. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
11. 11. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. J Thorac Cardiovasc Surg 1989;97:623-32.
12. 12. Fidler IJ. Origin and biology of cancer metastasis. Cytometry 1989;10:673-80.
13. 13. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
14. 14. Gusteron B. Are micrometastases clinically relevant? Br J Hosp Med 1991;47:247-8.
15. 15. Mansi JL, Mesker W, van Driel-Kulker AMJ, et al. Automated screening of bone marrow smears for micrometastases. J Immunol Methods 1988;112:105-11.
16. 16. Passlick B, Izbicki JR, Kubuschok B, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 1994;12:1827-32.
17. 17. Delfau MH, Kerckaert JP, Collyn H, et al. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990;4:1-5.
18. 18. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
19. 19. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-9.